The influence of smoking on bone loss and response to nasal estradiol

References

• Notelovitz M, Lenihan J P, McDermott M, Kerber I J, Nanavati N, Arce J. Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000; 95: 726–731
   PubMed Web of Science ®Google Scholar
• Manson J E, Hsia J, Johnson K C, et al. Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523–534
   PubMed Web of Science ®Google Scholar
• Cauley J A, Robbins J, Chen Z, et al. Women's Health Initiative Investigators. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003; 290: 1729–1738
   PubMed Web of Science ®Google Scholar
• Mokdad A H, Marks J S, Stroup D F, Gerberding J L. Actual causes of death in the United States, 2000. JAMA 2004; 291: 1238–1245
   PubMed Web of Science ®Google Scholar
• Tankó L B, Christiansen C. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Menopause 2004; 11: 104–109
   PubMed Web of Science ®Google Scholar
• Szulc P, Garnero P, Claustrat B, Marchand F, Duboeuf F, Delmas P D. Increased bone resorption in moderate smokers with low body weight: The MINOS study. J Clin Endocrinol Metab 2002; 87: 666–674
   PubMed Web of Science ®Google Scholar
• Ward K D, Klesges R C. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001; 68: 259–270
   PubMed Web of Science ®Google Scholar
• Cassidenti D L, Vijod A G, Vijod M A, Stanczyk F Z, Lobo R A. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1990; 163: 1953–1960
   PubMed Web of Science ®Google Scholar
• Jensen J, Christiansen C, Rodbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985; 313: 973–975
   PubMed Web of Science ®Google Scholar
• Bjarnason N H, Christiansen C. The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 2000; 85: 590–596
   PubMed Web of Science ®Google Scholar
• Bjarnason N H, Jørgensen C, Kremmer H, Alexandersen P, Christiansen C. Smoking reduces breast tenderness during oral hormone replacement therapy. Climacteric 2004; 7: 390–396
   PubMed Web of Science ®Google Scholar
• Bjarnason N H, Jørgensen H L, Byrjalsen I, Alexandersen P, Christiansen C. The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy. Climacteric 2007; 10: 480–490
   PubMed Web of Science ®Google Scholar
• Bjarnason N H, Byrjalsen I, Jørgensen H L, Christiansen C. The influence of smoking on uterine bleeding during sequential oral hormone therapy. Climacteric 2007; 10: 147–154
   PubMed Web of Science ®Google Scholar
• Geisler J, Omsjø H, Helle S I, Ekse D, Silsand T, Lønning P E. Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. J Endocrinol 1999; 162: 265–270
   PubMed Web of Science ®Google Scholar
• Mattsson L A, Christiansen C, Colau J C, et al. Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms. Am J Obstet Gynecol 2000; 182: 545–552
   PubMed Web of Science ®Google Scholar
• Devissaguet J P, Brion N, L'Hote O, Deloffre P. Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. Eur J Drug Metab Pharmacokinet 1999; 24: 265–271
   PubMed Web of Science ®Google Scholar
• Nielsen T F, Ravn P, Bagger Y Z, Warming L, Christiansen C. Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study. Osteoporosis Int 2004; 15: 168–174
   PubMed Web of Science ®Google Scholar
• Rosenquist C, Qvist P, Bjarnason N H, Christiansen C. Measurement of a more stable region of osteocalcin in human serum using two monoclonal antibodies in an enzyme-linked immunosorbent assay (ELISA). Clin Chem 1995; 41: 1439–1445
   PubMed Web of Science ®Google Scholar
• Bonde M, Qvist P, Fledelius C, Riis B J, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995; 80: 864–868
   PubMed Web of Science ®Google Scholar
• Bjarnason N H, Byrjalsen I, Hassager C, Haarbo J, Christiansen C. Low dose estradiol in combination with gestodene to prevent early postmenopausal bone loss. Am J Obstet Gynecol 2000; 183: 550–560
   PubMed Web of Science ®Google Scholar
• Bjarnason N H, Alexandersen P, Christiansen C. Number of years since menopause: Spontaneous bone loss is dependent, but response to HRT is independent. Bone 2002; 30: 637–642
   PubMed Web of Science ®Google Scholar
• Michnovicz J J, Hershcopf R J, Naganuma H, Bradlow H L, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 1986; 3151: 1305–1309
   Google Scholar
• Yamazaki H, Shaw P M, Guengerich F P, Shimada T. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 1998; 11: 659–665
   PubMed Web of Science ®Google Scholar
• Ding X, Kaminsky L S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 2003; 43: 149–173
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang Q-Y, Guo J, Zhou Y, Ding Z. Identification and functional characterization of a conserved nuclear factor 1-like element in the proximal promotor region of CYP1A2 gene specifically expressed in the liver and olfactory mucosa. J Biol Chem 2000; 275: 8895–8902
   PubMed Web of Science ®Google Scholar
• Wardlaw S A, Nikula K J, Kracko D A, Finch G L, Thornton-Manning J R, Dahl A R. Effect of cigarette smoke on CYP1A1, CYP1A2 and CYP2B1/2 of nasal mucosa in F344 rats. Carcinogenesis 1998; 19: 655–662
   PubMed Web of Science ®Google Scholar
• Jensen J, Christiansen C. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement. Am J Obstet Gynecol 1988; 159: 820–825
   PubMed Web of Science ®Google Scholar
• Bjarnason N H. Drug metabolism and variability. N Engl J Med 2005; 353: 955–956
   PubMed Web of Science ®Google Scholar
• Komulainen M, Kroger H, Tuppurainen M T, Heikkinen A M, Honkanen R, Saarikoski S. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial. Osteoporos Int 2000; 11: 211–218
   PubMed Web of Science ®Google Scholar
• Ravn P, Cizza G, Bjarnason N H, et al. for the early postmenopausal intervention cohort (EPIC) study group. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J Bone Miner Res 1999; 14: 1622–1627
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1996; 276: 1389–1396
   PubMed Web of Science ®Google Scholar